​

iCAD (ICAD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ICAD Stock Rating

iCAD stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (80.00%), 2 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 2 8 Strong Sell Sell Hold Buy Strong Buy

ICAD Price Target Upside V Benchmarks

TypeNameUpside
StockiCAD-
SectorHealthcare Stocks 23.68%
IndustryMedical Device Stocks16.34%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.76$3.76$3.76
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25--4--4
May, 25--4--4
Apr, 2513---4
Mar, 2513---4
Feb, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 16, 2025BTIGNeutraldowngrade
Apr 13, 2023JMP SecuritiesOutperformOutperformhold
Apr 26, 2022JMP SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.80$-0.45$-0.54$-0.27$-0.21---
Avg Forecast$-0.44$-0.40$-0.56$-0.30$-0.22$-0.22$-0.15$0.04
High Forecast$-0.39$-0.35$-0.56$-0.29$-0.17$-0.18$-0.14$0.04
Low Forecast$-0.49$-0.44$-0.57$-0.32$-0.25$-0.25$-0.16$0.04
Surprise %81.82%12.50%-3.57%-10.00%-4.55%---

Revenue Forecast

$15M $20M $25M $30M $35M $40M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$29.70M$33.64M$27.94M$17.32M$19.61M---
Avg Forecast$27.23M$33.64M$28.14M$20.00M$19.04M$19.67M$22.36M$31.15M
High Forecast$29.62M$36.59M$28.55M$20.19M$19.52M$20.71M$22.37M$32.79M
Low Forecast$24.98M$30.85M$27.86M$19.84M$18.76M$19.04M$22.35M$30.15M
Surprise %9.05%-0.01%-0.69%-13.40%3.01%---

Net Income Forecast

$-20M $-15M $-10M $-5M $0 $5M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-17.61M$-11.24M$-13.66M$-4.85M$-5.42M---
Avg Forecast$-13.26M$-8.98M$-14.44M$-7.01M$-5.30M$-5.92M$-3.82M$1.04M
High Forecast$-10.60M$-7.18M$-14.26M$-5.61M$-4.37M$-4.59M$-3.56M$1.09M
Low Forecast$-15.91M$-10.78M$-14.72M$-8.41M$-6.43M$-6.37M$-4.07M$981.69K
Surprise %32.85%25.22%-5.45%-30.86%2.17%---

ICAD Forecast FAQ

Is iCAD stock a buy?

iCAD stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that iCAD is a favorable investment for most analysts.

What is iCAD's price target?

iCAD's price target, set by 10 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $3.76.

How does iCAD stock forecast compare to its benchmarks?

iCAD's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the medical device stocks industry (16.34%).

What is the breakdown of analyst ratings for iCAD over the past three months?

  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is iCAD’s EPS forecast?

iCAD's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.22, marking a 4.76% increase from the reported $-0.21 in 2024. Estimates for the following years are $-0.15 in 2026, and $0.04 in 2027.

What is iCAD’s revenue forecast?

iCAD's average annual revenue forecast for its fiscal year ending in December 2025 is $19.67M, reflecting a 0.32% increase from the reported $19.61M in 2024. The forecast for 2026 is $22.36M, and $31.15M for 2027.

What is iCAD’s net income forecast?

iCAD's net income forecast for the fiscal year ending in December 2025 stands at $-5.916M, representing an 9.15% increase from the reported $-5.42M in 2024. Projections indicate $-3.816M in 2026, and $1.04M in 2027.